As Global Payers Become Monopolies, Biopharma Need To Demonstrate Value Earlier – AusBiotech Conference
This article was originally published in PharmAsia News
Executive Summary
Biopharma companies should define value propositions early and have a case for value differentiation at the discovery stage if they want to make a case to payers.